Surgery Partners (SGRY) Expected to Announce Earnings on Monday

Surgery Partners (NASDAQ:SGRY - Get Free Report) is projected to post its quarterly earnings results before the market opens on Monday, February 24th. Analysts expect Surgery Partners to post earnings of $0.40 per share and revenue of $828.01 million for the quarter. Persons interested in registering for the company's earnings conference call can do so using this link.

Surgery Partners Stock Down 0.6 %

NASDAQ:SGRY traded down $0.15 during mid-day trading on Thursday, reaching $25.67. The stock had a trading volume of 752,774 shares, compared to its average volume of 1,441,475. The stock has a market cap of $3.26 billion, a P/E ratio of -53.48, a PEG ratio of 19.34 and a beta of 2.60. The business's 50 day moving average is $22.41 and its 200 day moving average is $26.68. The company has a debt-to-equity ratio of 0.99, a current ratio of 1.80 and a quick ratio of 1.66. Surgery Partners has a fifty-two week low of $19.50 and a fifty-two week high of $34.10.

Analysts Set New Price Targets

Several research analysts have recently commented on SGRY shares. Macquarie restated an "outperform" rating and set a $34.00 price target on shares of Surgery Partners in a research note on Tuesday, November 19th. JPMorgan Chase & Co. cut their target price on Surgery Partners from $38.00 to $28.00 and set a "neutral" rating on the stock in a report on Tuesday, December 3rd. Royal Bank of Canada reduced their price target on Surgery Partners from $49.00 to $35.00 and set an "outperform" rating for the company in a research report on Wednesday, November 20th. Finally, Bank of America assumed coverage on Surgery Partners in a report on Monday, December 16th. They set a "buy" rating and a $30.00 price objective on the stock. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and seven have given a buy rating to the stock. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average price target of $36.56.

Insider Activity at Surgery Partners

In related news, CEO Jason Eric Evans sold 26,520 shares of the company's stock in a transaction on Friday, February 7th. The shares were sold at an average price of $25.65, for a total transaction of $680,238.00. Following the completion of the transaction, the chief executive officer now directly owns 560,698 shares in the company, valued at $14,381,903.70. This represents a 4.52 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Harrison R. Bane sold 56,315 shares of the stock in a transaction on Friday, February 7th. The shares were sold at an average price of $25.64, for a total transaction of $1,443,916.60. Following the completion of the sale, the insider now directly owns 107,037 shares of the company's stock, valued at approximately $2,744,428.68. This trade represents a 34.47 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 96,733 shares of company stock worth $2,480,106 in the last 90 days. 2.30% of the stock is owned by company insiders.

Surgery Partners Company Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.